LBO — LAKELAND REGIONAL MED CTR
IRR: 24.1% | MOIC: 2.94x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
24.1%
IRR
2.94x
MOIC
$399.6M
Entry EV
$792.0M
Exit EV
$205.6M
Equity Invested
Sources & Uses
S&UTotal · $399.6M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $155.2M | 38.8% | |
| Sub Debt | $38.8M | 9.7% | |
| Equity | $205.6M | 51.5% | |
| Enterprise Value | $388.0M | 97.1% | |
| Transaction Fees | $11.6M | 2.9% | |
| Total Uses | $399.6M | 100.0% |
Interpretation
INTAt 2.94x MOIC and 24.1% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $75.4M |
| Exit Ev | $792.0M |
| Net Debt At Exit | $187.4M |
| Equity At Exit | $604.7M |
| Equity Invested | $205.6M |
| Total Value Created | $399.0M |
| Value From Growth | $384.6M |
| Value From Multiple | $19.4M |
| Value From Deleveraging | $6.6M |